WHO WE ARE
We are an advanced data science IT and Financial company that focuses on disruptive Longevity and DeepTech innovation. Our analytical subsidiaries provide deep investment insights on the private and public markets via analytical reports and customized IT platforms we call Longevity Dashboards.
Analytics is at the core of our company, but it’s not the end goal. With all the data available to us, we make strategic decisions about our Group subsidiaries' core operations. One of our licensed subsidiaries - Longevity Financial Advisors - creates Structured Financial Products, such as thematic Actively Managed Certificates (AMCs). Another one invests in DeepTech and Longevity companies via venture capital funds and joint ventures.
WHY DO WE FOCUS ON LONGEVITY?
Simple reasons: money and impact. Longevity provides one of the biggest investment opportunities of our lifetime. All sectors under the Longevity industry umbrella comprise a whopping $27 trillion industry as of 2022, which is expected to grow to $32 trillion by 2026. Moreover, most Longevity-related companies contribute to social improvements, so it is not only an investment trend but a social cause for the greater good.
The global megatrend of Longevity industrialization has progressed substantially over the last years, with the notion of extending healthy human Longevity moving from the realm of fringe science to become a major strategic priority for large and reputable investors, financial corporations, and even governments. Therefore, making Longevity a new and perspective asset class.
Our open-access analytical reports are available here.